UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,587,746
-$1,141,807 QoQ
Shares Held
237,171
+2.3% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 47.73517841557358.ToString("F0")%
Shared 0.ToString("F0")%
None 52.26482158442642.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. ARQT ranks #61 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in ARQT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,587,746 | 237,171 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,729,553 | 231,734 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,599,681 | 244,015 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $5,674,396 | 404,736 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,364,294 | 279,047 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,901,790 | 280,100 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,573,225 | 276,691 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,546,144 | 273,779 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $430,532 | 81,080 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $568,129 | 59,615 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $655,765 | 59,615 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $498,996 | 33,716 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $365,001 | 19,100 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $638,702 | 29,972 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $577,260 | 29,972 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $621,618 | 29,972 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $716,030 | 29,972 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $817,935 | 29,972 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $613,316 | 21,200 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||